相关实验视频

Updated: Jun 9, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

对于法布里病的人体体实验模型:揭开疾病机制和治疗的新途径

Carla Borisch¹, Thomas Thum^1,2, Christian Bär^1,2,3

¹Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.

Journal of translational medicine

|October 25, 2024

概括

费布里病的研究需要更好的模型. 来自患者的细胞和3D有机体为了解这种多器官疾病和开发个性化治疗提供了有希望的体外方法.

科学领域:

生物医学研究生物医学研究
遗传学遗传学是一个
细胞生物学细胞生物学

背景情况:

法布里病是一种由GLA基因突变引起的遗传性疾病,导致糖脂积累和多器官损伤.
目前的体内模型无法充分复制多样化的患者表型和疾病机制.
了解法布里病需要先进的体外模型来捕捉疾病的复杂性.

研究的目的:

审查用于法布里病研究的人体体实验模型.
评估这些模型在了解疾病病理机制方面的有用性.
评估它们在开发和测试治疗策略中的作用.

主要方法:

关于体外模型的文献综述,包括来自患者的体细胞,细胞系,诱导多能干细胞 (iPSC) 和3D有机体模型.
分析这些模型如何复制法布里病表型和细胞缺陷.
评估它们在研究疾病进展和治疗干预中的应用.

主要成果:

患者衍生细胞和iPSC使个性化和突变特异性疾病建模成为可能.
三维 (3D) 的法布里病模型更紧密地模仿本地组织环境.
试验室模型已经推进了对法布里病病理机制和治疗疗效的理解.

结论:

人体体外模型,特别是iPSC和3D有机体,对于法布里病研究至关重要.
这些模型促进了个性化的方法,以了解疾病机制和开发向治疗.
进一步开发体外模型对于推进法布里病治疗策略至关重要.

更多相关视频

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...